Cogent Biosciences, Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 8.36M9.73M22.50M7.87M
Gross Profit 8.36M9.73M22.50M7.87M
Operating items
Research & Development 29.83M38.28M43.71M25.74M
Selling, General & Administrative 4.68M7.45M10.97M17.42M
Other Operating Expenses 46.91M
Operating Expenses 34.51M45.74M54.68M90.07M
Operating Income -26.15M-36.01M-32.18M-82.20M
EBIT -26.15M-36.01M-32.18M-82.20M
Non-operating items
Interest & Investment Income 0.39M1.15M0.27M0.14M
Other Non Operating Income 0.27M0.32M0.08M0.78M
Non Operating Income 0.66M1.47M0.34M7.39M
Net income details
EBT -25.77M-34.85M-31.91M-82.06M
Profit After Tax -25.49M-34.53M-31.83M-74.81M
Income from Continuing Operations -25.77M-34.85M-31.91M-82.06M
Consolidated Net Income -25.77M-34.85M-31.91M-82.06M
Income towards Parent Company -25.77M-34.85M-31.91M-82.06M
Preferred Dividend Payments 0.07M0.02M
Net Income towards Common Stockholders -25.56M-34.55M-31.83M-82.06M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 7.40M7.50M7.67M11.34M39.85M69.89M86.12M110.46M
EBITDA -25.48M-34.53M-31.82M-74.81M